HHS Moves To Restore Public Trust in Vaccines

HHS Moves To Restore Public Trust in Vaccines

Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agencies, pharmaceutical companies or vaccines themselves, public confidence is waning.

New COVID-19 Vaccine Recommendations Cause Confusion Among Public, Health Care Providers

The conflicting information and abrupt changes are likely to contribute to a lack of trust and confidence in health care, Lauren Angelo, PharmD, MBA, said.

Unreliable Vaccine Information and the Erosion of Science

This Viewpoint explores how appointing vaccine skeptics to positions of power in the US government contributes to the spread of unreliable information, subverts public confidence in vaccines, and undermines the integrity of public health.

Former HHS lawyer on Novavax delay: Mixing politics and approvals 'imperils' public health

The FDA's infusion of a political appointee into the approval decision for Novavax's Covid-19 vaccine "imperils public health and innovation," former HHS employees and others wrote in a JAMA viewpoint on ...